Mezzasalma Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.31M | Hold |
2,500
| – | – | 0.39% | 44 |
|
|
2025
Q1 | $1.59M | Hold |
2,500
| – | – | 0.55% | 38 |
|
|
2024
Q4 | $1.78M | Hold |
2,500
| – | – | 0.57% | 34 |
|
|
2024
Q3 | $2.63M | Hold |
2,500
| – | – | 1.04% | 28 |
|
|
2024
Q2 | $2.63M | Sell |
2,500
-33
| -1% | -$34.7K | 1.13% | 27 |
|
|
2024
Q1 | $2.44M | Buy |
2,533
+33
| +1% | +$31.8K | 1.15% | 19 |
|
|
2023
Q4 | $2.2M | Sell |
2,500
-10
| -0.4% | -$8.78K | 1.2% | 18 |
|
|
2023
Q3 | $2.07M | Hold |
2,510
| – | – | 1.27% | 19 |
|
|
2023
Q2 | $1.8M | Buy |
2,510
+10
| +0.4% | +$7.19K | 1.09% | 21 |
|
|
2023
Q1 | $2.05M | Hold |
2,500
| – | – | 1.45% | 19 |
|
|
2022
Q4 | $1.8M | Sell |
2,500
-9
| -0.4% | -$6.49K | 1.57% | 18 |
|
|
2022
Q3 | $1.73M | Buy |
2,509
+9
| +0.4% | +$6.2K | 1.37% | 16 |
|
|
2022
Q2 | $1.48M | Hold |
2,500
| – | – | 1.25% | 17 |
|
|
2022
Q1 | $1.75M | Hold |
2,500
| – | – | 1.09% | 19 |
|
|
2021
Q4 | $1.58M | Hold |
2,500
| – | – | 0.85% | 25 |
|
|
2021
Q3 | $1.51M | Hold |
2,500
| – | – | 0.85% | 26 |
|
|
2021
Q2 | $1.4M | Buy |
2,500
+500
| +25% | +$279K | 0.77% | 30 |
|
|
2021
Q1 | $946K | Buy |
2,000
+1,000
| +100% | +$473K | 0.61% | 36 |
|
|
2020
Q4 | $483K | Buy |
+1,000
| New | +$483K | 0.31% | 47 |
|